Ursprung des Netzwerks ersten Grades von Miles Houslay
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Mironid Ltd.
Mironid Ltd. Pharmaceuticals: MajorHealth Technology Mironid Ltd. develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins. The company was founded by Miles Houslay, Paul Barton Rodgers, Elizabeth Fairley, Julia Adam, David Adams and Nigel Pyne in 2014 and is headquartered in North Lanarkshire, the United Kingdom.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Miles Houslay
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Psynova Neurotech Ltd.
Psynova Neurotech Ltd. BiotechnologyHealth Technology Psynova Neurotech Ltd. provides commercial development and exploitation of novel biomarkers for Neuropsychiatric and other mental illnesses. The company was founded by Sabine Bahn on August 1, 2005 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chairman | |
Ampika Ltd.
Ampika Ltd. Drugstore ChainsRetail Trade Ampika Ltd. discovers and develops drugs. It develops consumer products and prescription drugs from plant-based compounds. Its products includes cardiovascular protection, anti-infectives, diabetes, oncology, dermatological conditions and neurological. The company was founded by Francoise Barbira Freedman, Margaret Adey, Paul Rodgers and Jonathan Mark Treherne in May 2003 and is headquartered in Cambridge, the United Kingdom. | Drugstore Chains | Founder | |
Ithaka Life Sciences Ltd.
Ithaka Life Sciences Ltd. Miscellaneous Commercial ServicesCommercial Services Ithaka Life Sciences Ltd. provides advisory, guidance, and support for the life science industry. The British company was founded by Paul Barton Rodgers, who has been the CEO since incorporation. | Miscellaneous Commercial Services | Chief Executive Officer | |
ProteinLogic Ltd.
ProteinLogic Ltd. Packaged SoftwareTechnology Services ProteinLogic Ltd. has developed a diagnostic technology platform called immiprint®, which detects non-obvious diagnostic patterns in soluble immune proteins in the blood and other body fluids through machine learning. ProteinLogic is based in Cambridge, UK. These patterns form unique signatures of disease presence, stage, and potential response to treatment. The immiprint® technology has been clinically validated with the development of a signature in blood for the ruling out of active tuberculosis (TB), meeting the stringent criteria of the WHO for such a diagnostic test. The British company expects to create considerable additional value through the validation of other immiprint® signatures in its early stage development pipeline, with a focus on infectious, autoimmune, and inflammatory diseases. | Packaged Software | Chairman |
Statistik
International
Vereinigtes Königreich | 6 |
Sektoral
Health Technology | 3 |
Retail Trade | 2 |
Commercial Services | 2 |
Technology Services | 2 |
Operativ
Founder | 8 |
Corporate Officer/Principal | 4 |
Director/Board Member | 3 |
Chairman | 3 |
Chief Executive Officer | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Paul Barton Rodgers | 6 |
Elizabeth Fairley | 1 |
Julia Adam | 1 |
David Adams | 1 |
Nigel Pyne | 1 |
- Börse
- Insiders
- Miles Houslay
- Unternehmensverbindungen